Amalgamated Bank’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3K | Hold |
3,609
| – | – | ﹤0.01% | 2900 |
|
2025
Q1 | $3K | Hold |
3,609
| – | – | ﹤0.01% | 2773 |
|
2024
Q4 | $5K | Hold |
3,609
| – | – | ﹤0.01% | 2711 |
|
2024
Q3 | $4K | Hold |
3,609
| – | – | ﹤0.01% | 2802 |
|
2024
Q2 | $6K | Buy |
3,609
+1,029
| +40% | +$1.71K | ﹤0.01% | 2675 |
|
2024
Q1 | $6K | Sell |
2,580
-10,844
| -81% | -$25.2K | ﹤0.01% | 2629 |
|
2023
Q4 | $45K | Buy |
13,424
+2,537
| +23% | +$8.51K | ﹤0.01% | 2297 |
|
2023
Q3 | $41K | Sell |
10,887
-20,311
| -65% | -$76.5K | ﹤0.01% | 2330 |
|
2023
Q2 | $133K | Buy |
31,198
+580
| +2% | +$2.47K | ﹤0.01% | 1972 |
|
2023
Q1 | $209K | Sell |
30,618
-2,181
| -7% | -$14.9K | ﹤0.01% | 1784 |
|
2022
Q4 | $260K | Hold |
32,799
| – | – | ﹤0.01% | 1758 |
|
2022
Q3 | $315K | Buy |
32,799
+386
| +1% | +$3.71K | ﹤0.01% | 1647 |
|
2022
Q2 | $235K | Buy |
32,413
+1,126
| +4% | +$8.16K | ﹤0.01% | 1802 |
|
2022
Q1 | $404K | Sell |
31,287
-1,931
| -6% | -$24.9K | ﹤0.01% | 1643 |
|
2021
Q4 | $530K | Sell |
33,218
-876
| -3% | -$14K | ﹤0.01% | 1548 |
|
2021
Q3 | $548K | Sell |
34,094
-666
| -2% | -$10.7K | ﹤0.01% | 1526 |
|
2021
Q2 | $481K | Buy |
+34,760
| New | +$481K | ﹤0.01% | 1664 |
|
2020
Q2 | – | Sell |
-10,380
| Closed | -$168K | – | 1512 |
|
2020
Q1 | $168K | Sell |
10,380
-432
| -4% | -$6.99K | ﹤0.01% | 1409 |
|
2019
Q4 | $195K | Buy |
+10,812
| New | +$195K | ﹤0.01% | 1647 |
|
2019
Q3 | – | Sell |
-9,950
| Closed | -$220K | – | 1783 |
|
2019
Q2 | $220K | Buy |
+9,950
| New | +$220K | 0.01% | 1529 |
|